Lobato E B, Urdaneta F, Martin T D, Gravenstein N
Department of Anesthesiology, University of Florida College of Medicine, Gainesville, USA.
J Cardiothorac Vasc Anesth. 2000 Feb;14(1):9-11. doi: 10.1016/s1053-0770(00)90047-8.
To compare changes on grafted internal mammary artery (IMA) flow after cardiopulmonary bypass in response to the administration of milrinone or epinephrine.
Prospective and randomized.
University-affiliated hospital.
Twenty consenting, adult patients undergoing CABG.
Patients were randomized to receive either milrinone, 50 microg/kg, or epinephrine, 0.03 microg/kg/min, immediately after cardiopulmonary bypass. IMA flow was measured with a laser Doppler flow probe before and after the administration of either drug.
Baseline grafted IMA flow was similar for both groups (milrinone, 38+/-14 mL/min; epinephrine, 33+/-10 mL/min). In patients who received milrinone, flow increased by 24% to 50+/-17 mL/min, p<0.05; whereas with epinephrine, it remained essentially unchanged (33+/-10 v. 31+/-11 mL/min).
This study confirms that the vasodilatory effect of milrinone on the IMA is also present after its anastomosis, whereas low-dose epinephrine exhibits neither beneficial nor adverse effects. It is suggested that in the absence of excessive vasodilation, milrinone should be considered as a first-line inotrope after coronary artery bypass graft surgery, to achieve an increase in contractility and IMA artery flow.
比较体外循环后给予米力农或肾上腺素对移植的乳内动脉(IMA)血流的影响。
前瞻性随机研究。
大学附属医院。
20例接受冠状动脉旁路移植术(CABG)的成年患者,均表示同意参与研究。
患者在体外循环后立即随机接受50μg/kg米力农或0.03μg/kg/min肾上腺素治疗。在给予任何一种药物之前和之后,用激光多普勒血流探头测量IMA血流。
两组患者移植IMA的基线血流相似(米力农组,38±14 mL/min;肾上腺素组,33±10 mL/min)。接受米力农治疗的患者血流增加24%,至50±17 mL/min,p<0.05;而使用肾上腺素的患者血流基本保持不变(33±10 vs 31±11 mL/min)。
本研究证实米力农对IMA的血管舒张作用在其吻合后也存在,而低剂量肾上腺素既无有益作用也无不良影响。建议在没有过度血管舒张的情况下,米力农应被视为冠状动脉旁路移植术后一线的正性肌力药物,以增加心肌收缩力和IMA血流。